Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial Meeting Abstract
| Authors: | Tap, W. D.; Bhadri, V.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; de Sande, M. V.; Bernthal, N. M.; Pousa, A. L.; Razak, A. R. A.; Italiano, A.; Ahmed, M.; Le Cesne, A.; Tait, C.; Zarins, F.; Harrow, B.; Sharma, M. G.; Ruiz-Soto, R.; Sherman, M. L.; Blay, J. Y.; Gelderblom, H.; on behalf of the MOTION Investigators |
| Abstract Title: | Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402658 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11500 |
| Notes: | Meeting Abstract: 11500 -- Source: Wos |
